Skip to content

Vitamin D Supplementation in Healthy Adults in Prolonged Endurance Exercise

Effects of Vitamin D Supplementation on Biochemical Reaction and Skeletal Muscle Synthesis in Prolonged Endurance Exercise and Cluster Set Configurations of Resistance Training

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05781620
Enrollment
50
Registered
2023-03-23
Start date
2022-10-21
Completion date
2024-02-29
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The purpose of this study is to investigate the effects of vitamin D supplementation on biochemistry response and skeletal muscle synthesis in prolonged endurance exercise.

Detailed description

Endurance exercise mode will be used to evaluate the effects of vitamin D supplementation on cardiac biomarkers, metabolic hormones, oxidative damage, and inflammation responses. An independent samples and dose titration design will be used to assign 30 participants to the experimental group (n = 15) or placebo group (n = 15). All participants in the experimental group will have serum 25(OH)D concentrations higher than 48 ng/mL after supplementation period. After the prolonged endurance exercise test, the blood samples will be collected for analyzing biomarkers. Data will be analyzed by Two-way mixed design ANOVA.

Interventions

DIETARY_SUPPLEMENTVitamin D

Participants received 5,000 IU of vitamin D orally twice daily for 4 weeks. If the serum 25(OH)D concentration exceeds 48 ng/mL, the intervention remains the same. However, if the serum 25(OH)D concentration is under 48 ng/mL, the dosage would increase by 2,500 IU. The principle remains the same at week 6.

DIETARY_SUPPLEMENTMedium-chain triglycerides

Participants received the same amount of placebo matching vitamin D orally twice daily.

Sponsors

Panion & BF Biotech Inc.
CollaboratorINDUSTRY
Taipei Medical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

A double-blind, matched-pair study design

Intervention model description

An independent samples and dose titration design will be used to assign participants to the experimental group or placebo group.

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* The volunteers included have conditions as stated below : 1. male adult between 20-40 years old without any history of cardiovascular, liver, kidney and diabetes disease 2. no acute sport injury 3. male adult whose concentration of 25(OH)D is under 30 ng/mL, and maximal oxygen consumption is over 40 ml/kg/min 4. did not participated in any clinical trials or research in the last 3 months before our experiment 5. no supplements were taken during the experimental period 6. were requested to maintain their regular daily life style and avoid alcohol intake

Exclusion criteria

* The volunteers were excluded if they have the situation stated below: 1. history of cardiovascular, liver, kidney and diabetes disease 2. acute sport injury 3. their concentration of 25(OH)D is over 30 ng/mL, or maximal oxygen consumption is under 40 ml/kg/mint 4. participated in any clinical trials or experimental research in the last 3 months before our experiment 5. taking supplement during the experimental period 6. did not maintain their regular eating habit or drink alcohol

Design outcomes

Primary

MeasureTime frame
Concentration of LDHbefore exercise
Concentration of IL-6before exercise
Concentration of NT-proBNPbefore exercise
Concentration of IL-8before exercise
Concentration of cTnIbefore exercise
Concentration of CK-MBbefore exercise
Concentration of IL-10before exercise
Concentration of CKbefore exercise
Concentration of Testosteronebefore exercise
Concentration of Cortisolbefore exercise
Concentration of β-endorphinbefore exercise
Concentration of Growth hormonebefore exercise
Concentration of IGF-1before exercise
Concentration of TBARSbefore exercise
Concentration of PCbefore exercise
Concentration of SODbefore exercise
Concentration of Catalasebefore exercise
Concentration of TNF-αbefore exercise
Concentration of IL-15before exercise
Concentration of leukocytebefore exercise
Concentration of neutrophilbefore exercise
Concentration of eosinophilbefore exercise
Concentration of basophilbefore exercise
Concentration of monocytebefore exercise
Concentration of lymphocytebefore exercise
Concentration of CD4+before exercise
Concentration of CD8+before exercise
Concentration of CD19+before exercise
Concentration of CD56+before exercise

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026